Tech Company Financing Transactions
AMSilk Funding Round
AMSilk, operating out of Neuried / Munich, secured $27.3 million in funding from Athos, Cargill Ventures and MIG Capital.
Transaction Overview
Company Name
Announced On
4/4/2023
Transaction Type
Venture Equity
Amount
$27,284,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to accelerate industrial scale-up and expand commercial operations of bio-fabricated silk protein materials.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
Anna-Sigmund-Str. 1-3
Neuried / Munich, 82061
DE
Neuried / Munich, 82061
DE
Phone
Website
Email Address
Overview
AMSilk is the world's first industrial supplier of smart biotech materials with current scale-up phase by applying an outstanding technology protein platform based on silk proteins for a variety of applications such as textile fibers, medical devices and consumer goods. Always one step ahead, the Company aims to make smart biotech materials a part of everyday life through its customizable solutions. Furthermore, AMSilk's smart biotech materials outperform existing, fossil-based products not only through their optimal relationship between performance and positive environmental impact, but also through the adaptability of multiple benefits to a broad range of meaningful applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ulrich Scherbel
Chief Financial Officer
Arne Treinies
Browse more venture capital transactions:
Prev: 4/4/2023: Forefront RF venture capital transaction
Next: 4/4/2023: TerraPay venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs